3D structures from the PDB for "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A]" AND "BDBM519"
(Proteins have >= 85% sequence identity and ligands are exact matches)

	Seq Identity	Jmol Display	PDB Title
3NDT	100%		HIV-1 PROTEASE SAQUINAVIR:RITONAVIR 1:1 COMPLEX STRUCTURE
3OXC	100%		WILD TYPE HIV-1 PROTEASE WITH ANTIVIRAL DRUG SAQUINAVIR
3TL9	100%		CRYSTAL STRUCTURE OF HIV PROTEASE MODEL PRECURSOR/SAQUINAVIR COMPLEX
3TKG	100%		CRYSTAL STRUCTURE OF HIV MODEL PROTEASE PRECURSOR/SAQUINAVIR COMPLEX
3NDU	100%		HIV-1 PROTEASE SAQUINAVIR:RITONAVIR 1:5 COMPLEX STRUCTURE
2NMY	99%		CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A INHIBITOR SAQUINAVIR
2NMZ	99%		CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A INHIBITOR SAQUINAVIR
3PWR	99%		HIV-1 PROTEASE MUTANT L76V COMPLEXED WITH SAQUINAVIR
2NNK	99%		CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A INHIBITOR SAQUINAVIR
2NNP	99%		CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A INHIBITOR SAQUINAVIR
3CYX	99%		CRYSTAL STRUCTURE OF HIV-1 MUTANT I50V AND INHIBITOR SAQUINAVIRA
3D1Y	99%		CRYSTAL STRUCTURE OF HIV-1 MUTANT I54V AND INHIBITOR SAQUINA
3D1X	99%		CRYSTAL STRUCTURE OF HIV-1 MUTANT I54M AND INHIBITOR SAQUINAVIR
5KQX	98%		PROTEASE E35D-SQV
3S56	97%		HIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG SAQUINAVIR
7DT9	94%		D30N HIV PROTEASE IN COMPLEX WITH SAQUINAVIR
1HXB	94%		HIV-1 PROTEINASE COMPLEXED WITH RO 31-8959
5KR2	94%		PROTEASE PR5-SQV
4Q5M	94%		D30N TETHERED HIV-1 PROTEASE DIMER/SAQUINAVIR COMPLEX
4QGI	93%		X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE VARIANT G48T/L89M IN COMPLEX WITH SAQUINAVIR
3N3I	93%		CRYSTAL STRUCTURE OF G48V/C95F TETHERED HIV-1 PROTEASE/SAQUINAVIR COMPLEX
1FB7	92%		CRYSTAL STRUCTURE OF AN IN VIVO HIV-1 PROTEASE MUTANT IN COMPLEX WITH SAQUINAVIR: INSIGHTS INTO THE MECHANISMS OF DRUG RESISTANCE
3EL4	91%		CRYSTAL STRUCTURE OF INHIBITOR SAQUINAVIR (SQV) COMPLEXED WITH THE MULTIDRUG HIV-1 PROTEASE VARIANT L63P/V82T/I84V
1C6Z	87%		ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP.